Peptides have unique properties that make them useful drug candidates for diverse indications, including allergy, infectious disease and cancer. Some peptides are intrinsically bioactive, while others can be used to induce precise immune responses by defining a minimal immunogenic region. The limitations of peptides, such as metabolic instability, short half-life and low immunogenicity, can be addressed by strategies such as multimerization or fusion to carriers, to improve their pharmacological properties. The remaining major drawback is the cost of production using conventional chemical synthesis, which is also difficult to scale-up. Over the last 15 years, plants have been shown to produce bioactive and immunogenic peptides economically and with the potential for large-scale synthesis. The production of peptides in plants is usually achieved by the genetic fusion of the corresponding nucleotide sequence to that of a carrier protein, followed by stable nuclear or plastid transformation or transient expression using bacterial or viral vectors. Chimeric plant viruses or virus-like particles can also be used to display peptide antigens, allowing the production of polyvalent vaccine candidates. Here we review progress in the field of plant-derived peptides over the last 5 years, addressing new challenges for diverse pathologies. © 2012 Springer-Verlag.

Cited By :19Export Date: 17 July 2015CODEN: PCRPDCorrespondence Address: Avesani, L.; Dipartimento di Biotecnologie, Università degli Studi di Verona, Strada Le Grazie, 15, 37134 Verona, Italy; email: linda.avesani@univr.itChemicals/CAS: Peptides; Vaccines, SyntheticReferences: Andrianova, E.P., Krementsugskaia, S.R., Lugovskaia, N.N., Mayorova, T.K., Borisov, V.V., Eldarov, M.A., Ravin, N.V., Skryabin, K.G., Foot and mouth disease virus polyepitope protein produced in bacteria and plants induces protective immunity in guinea pigs (2011) Biochemistry (Mosc), 76, pp. 339-346;Arazi, T., Slutsky, S.G., Shiboleth, Y.M., Wang, Y., Rubinstein, M., Barak, S., Yang, J., Gal-On, A., Engineering zucchini yellow mosaic potyvirus as a non-pathogenic vector for expression of heterologous proteins in cucurbits (2001) J Biotechnol, 87, pp. 67-82; Bandurska, K., Brodzik, R., Spitsin, S., Kohl, T., Portocarrero, C., Smirnov, Y., Pogrebnyak, N., Golovkin, M., Plant-produced hepatitis B core protein chimera carrying anthrax protective antigen domain-4 (2008) Hybridoma (Larchmt), 27, pp. 241-247; Basaran, P., Rodriguez-Cerezo, E., Plant molecular farming: opportunities and challenges (2008) Crit Rev Biotechnol, 28, pp. 153-172; Black, R.E., Cousens, S., Johnson, H.L., Lawn, J.E., Rudan, I., Bassani, D.G., Jha, P., Mathers, C., Global, regional and national causes of child mortality in 2008: a systematic analysis (2010) Lancet, 375, pp. 1969-1987; Boivin, E.B., Lepage, E., Matton, D.P., de Crescenzo, G., Jolicoeur, M., Transient expression of antibodies in suspension plant cell suspension cultures is enhanced when co-transformed with the tomato bushy stunt virus p19 viral suppressor of gene silencing (2010) Biotechnol Prog, 26, pp. 1534-1543; Bolhassani, A., Safaiyan, S., Rafati, S., Improvement of different vaccine delivery systems for cancer therapy (2011) Mol Cancer, 10, p. 3; Branco, M.C., Sigano, D.M., Schneider, J.P., Materials from peptide assembly: towards the treatment of cancer and transmittable disease (2011) Curr Opin Chem Biol, 15, pp. 427-434; Bray, B.L., Large-scale manufacture of peptide therapeutics (2003) Nat Rev Drug, 2, pp. 587-593; Breckpot, K., Escors, D., Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification (2009) Endocr Metab Immune Disord Drug Targets, 9, pp. 328-343; Burnet, F.M., The concept of immunological surveillance (1970) Prog Exp Tumor Res, 13, pp. 1-27; Campbell, J.D., Buckland, K.F., McMillan, S.J., Kearley, J., Oldfield, W.L., Stern, L.J., Gronlund, H., Larche, M., Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression (2009) J Exp Med, 206, pp. 1535-1547; Castilho, A., Strasser, R., Stadlmann, J., Grass, J., Jez, J., Gattinger, P., Kunert, R., Steinkellner, H., In planta protein sialylation through overexpression of the respective mammalian pathway (2010) J Biol Chem, 285, pp. 15923-15930; Chua, B.Y., Zeng, W.G., Lau, Y.F., Jackson, D.C., Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups (2007) Vaccine, 25, pp. 92-101; Circelli, P., Donini, M., Villani, M.E., Benvenuto, E., Marusic, C., Efficient Agrobacterium-based transient expression system for the production of biopharmaceuticals in plants (2010) Bioeng Bugs, 1, pp. 221-224; Craik, D.J., Simonsen, S., Daly, N.L., Thecyclotides: novel macrocyclic peptides as scaffolds in drug design (2002) Curr Opin Discov Dev, 5, pp. 251-260; Croft, N.P., Purcell, A.W., Peptidomimetics: modifying peptides in the pursuit of better vaccines (2011) Expert Rev Vaccines, 10, pp. 211-226; Crotty, S., Felgner, P., Davies, H., Glidewell, J., Villareal, L., Ahmed, R., Cutting edge: long-term B cell memory in humans after smallpox vaccination (2003) J Immunol, 171, pp. 4969-4973; Dalsgaard, K., Uttenthal, A., Jones, T.D., Xu, F., Merryweather, A., Hamilton, W.D., Langeveld, J.P., Rodgers, P.B., Plant-derived vaccine protects target animals against a viral disease (1997) Nat Biotechnol, 15, pp. 248-252; Daniell, H., Singh, N.D., Mason, H., Streatfield, S.J., Plant-made vaccine antigens and biopharmaceuticals (2009) Trends Plant Sci, 14, pp. 669-679; Davidson, M.H., Cardiovascular effects of glucagonlike peptide-1 agonist (2011) Am J Cardiol, 108, pp. 33-41; Ducat, E., Deprez, J., Gillet, A., Noel, A., Evrard, B., Peulen, O., Piel, G., (2011) Nuclear delivery of a therapeutic peptide by long circulating pH-sensitive liposomes: Benefits over classical vesicles, , Int J Pharm 25 (Epub ahead of print). doi: 10. 1016/j. ijpharm. 2011. 08. 034; Durham, S.R., Walker, S.M., Varga, E.M., Jacobson, M.R., O’Brien, F., Noble, W., Long-term clinical efficacy of grass-pollen immunotherapy (1999) N Engl J Med, 341, pp. 468-475; Ebner, C., Siemann, U., Bohle, B., Willheim, M., Wiedermann, U., Schenk, S., Klotz, F., Scheiner, O., Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen (1997) Clin Exp Allergy, 27, pp. 1007-1015; Edimayr, J., Niespodziana, K., Focke-Tejkl Linhart, B., Valenta, R., Allergen-specific immunotherapy: towards combination vaccines for allergic and infectious diseases (2011) Curr Top Microbiol Immunol, 820, pp. 121-140; Elgaard, L., Helenius, A., Quality control in the endoplasmic reticulum (2003) Natl Rev Mol Cell Biol, 4, pp. 181-191; Fellrath, J.M., Kettner, A., Dufour, N., Frigerio, C., Schneeberger, D., Leimgruber, A., Corradin, G., Spertini, F., Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial (2003) J Allergy Clin Immunol, 111, pp. 854-861; Fischer, R., Schillberg, S., Hellwig, S., Twyman, R.M., Drossard, J., GMP issues for plant-derived recombinant proteins (2011) Biotechnol Adv, , doi: 10. 1016/j. biotechadv. 2011. 08. 007; Frolova, O.Y., Petrunia, I.V., Komarova, T.V., Kosorukov, V.S., Sheval, E.V., Gleba, Y.Y., Dorokhov, Y.L., Trastuzumab-binding peptide display by Tobacco mosaic virus (2010) Virology, 407, pp. 7-13; Giuliani, A., Rinaldi, A.C., Beyond natural antimicrobial peptides: multimeric peptides and other peptidomimetic approaches (2011) Cell Mol Life Sci, 68, pp. 2255-2266; Gomord, V., Sourrouille, C., Fitchette, A.C., Bardor, M., Pagny, S., Lerouge, P., Faye, L., Production and glycosylation of plant-made pharmaceuticals: the antibodies as a challenge (2004) Plant Biotechnol J, 2, pp. 83-100; Gomord, V., Fitchette, A.C., Menu-Bouaouiche, L., Saint-Jore-Dupas, C., Plasson, C., Michaud, D., Faye, L., Plant-specific glycosylation patterns in the context of therapeutic protein production (2010) Plant Biotechnol J, 8, pp. 564-587; Gupta, R.K., Rost, B.E., Relyveld, E., Siber, G.R., Adjuvant properties of aluminium and calcium compounds (1995) Vaccine Design: The Subunit and Adjuvant Approach, pp. 229-248. , M. F. Powell and M. J. Newman (Eds.), New York: Plenum Press; Hashizume, F., Hino, S., Kakehashi, M., Okajima, T., Nadano, D., Aoki, N., Matsuda, T., Development and evaluation of transgenic rice seeds accumulating a type II-collagen tolerogenic peptide (2008) Transgenic Res, 17, pp. 1117-1129; Hoft, D.F., Brusic, V., Sakala, I.G., Optimizing vaccine development (2011) Cell Microbiol, 13, pp. 934-942; Huy, N.X., Yang, M.S., Kim, T.G., Expression of a cholera toxin B subunit-neutralizing epitope of the porcine epidemic diarrhea virus fusion gene in transgenic lettuce (Lactuca sativa L.) (2011) Mol Biotechnol, 48, pp. 201-209; Jegerlehner, A., Tissot, A., Lechner, F., Sebbel, P., Erdmann, I., Kundig, T., Bachi, T., Bachmann, M.F., A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses (2002) Vaccine, 20, pp. 3104-3112; Jones, S.M., Pons, L., Roberts, J.L., Scurlock, A.M., Perry, T.T., Kulis, M., Shreffler, W.G., Burks, A.W., Clinical efficacy and immune regulation with peanut oral immunotherapy (2009) J Allergy Clin Immunol, 124, pp. 292-300; Jutel, M., Pichler, W.J., Skrbic, D., Urwyler, A., Dahinden, C., Muller, U.R., Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures (1995) J Immunol, 154, pp. 4187-4194; Komarova, T.V., Baschieri, S., Donini, M., Marusic, C., Benvenuto, E., Dorokhov, Y.L., Transient expression systems for plant-derived bipharmaceuticals (2010) Expert Rev Vaccines, 9, pp. 859-876; Lai, H., Chen, Q., Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations (2011) Plant Cell Rep, , doi: 10. 1007/s00299-011-1196-6; Larché, M., Peptide immunotherapy for allergic diseases (2007) Allergy, 62, pp. 325-331; Larman, H.B., Zhao, Z., Laserson, U., Li, M.Z., Ciccia, A., Gakidis, M.A., Church, G.M., Elledge, S.J., Autoantigen discovery with a synthetic human peptidome (2011) Nat Biotechnol, 29, pp. 535-541; Lee, S.B., Li, B., Jin, S., Daniell, H., Expression and characterization of antimicrobial peptides Retrocyclin-101 and Protegrin-1 in chloroplasts to control viral and bacterial infections (2011) Plant Biotechnol J, 9, pp. 100-115; Lentz, E.M., Segretin, M.E., Morgenfeld, M.M., Wirth, S.A., Dus Santos, M.J., Mozgovoj, M.V., Wigdorovitz, A., Bravo-Almonacid, F.F., High expression level of a foot and mouth disease virus epitope in tobacco transplastomic plants (2010) Planta, 231, pp. 387-395; Levine, M.M., Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine (2010) BMC Biol, 8, p. 129; Lico, C., Capuano, F., Renzone, G., Donini, M., Marusic, C., Scaloni, A., Benvenuto, E., Baschieri, S., Peptide display on Potato virus X: molecular features of the coat protein-fused peptide affecting cell-to-cell and phloem movement of chimeric virus particles (2006) J Gen Virol, 87, pp. 3103-3112; Lico, C., Chen, Q., Santi, L., Viral vectors for production of recombinant proteins in plants (2008) J Cell Physiol, 216, pp. 366-377; Lico, C., Mancini, C., Italiani, P., Betti, C., Boraschi, D., Benvenuto, E., Baschieri, S., Plant-produced potato virus X chimeric particles displaying an influenza virus-derived peptide activate specific CD8+ T cells in mice (2009) Vaccine, 27, pp. 5069-5076; Lien, S., Lowman, H.B., Therapeutic peptides (2003) Trends Biotechnol, 21, pp. 556-562; Liénard, D., Sourrouille, C., Gomord, V., Faye, L., Pharming and transgenic plants (2007) Biotechnol Annu Rev, 13, pp. 115-147; Magis, D., Schoenen, J., Treatment of migraine: update on new therapies (2011) Curr Opin Neurol, 24, pp. 203-210; Marillonnet, S., Giritch, A., Gils, M., Kandzia, R., Klimyuc, V., Gleba, Y., In planta engineering of viral RNA replicons: efficient assembly by recombination of DNA modules delivered by Agrobacterium (2004) Proc Natl Acad Sci USA, 101, pp. 6852-6857; Masuta, C., Yamana, T., Tacahashi, Y., Uyeda, I., Sato, M., Ueda, S., Matsumura, T., Development of clover yellow vein virus as an efficient, stable gene-expression system for legume species (2000) Plant J, 23, pp. 539-546; Matoba, N., Kajiura, H., Cherni, I., Doran, J.D., Bomsel, M., Fujiyama, K., Mor, T.S., Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR (2009) Plant Biotechnol J, 7, pp. 129-145; Meshcheryakova, Y.A., Eldarov, M.A., Migunov, A.I., Stepanova, L.A., Repko, I.A., Kiselev, C.I., Lomonossoff, G.P., Skryabin, K.G., Cowpea mosaic virus chimeric particles bearing the ectodomain of matrix protein 2 (M2E) of the influenza A virus: production and characterization (2009) Appl Mol Biol, 43, pp. 685-694; Möbs, C., Slotosch, C., Löffler, H., Jakob, T., Hertl, M., Pfützner, W., Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation (2010) J Immunol, 184, pp. 2194-2203; Moldaver, D., Larché, M., Immunotherapy with peptides (2011) Allergy, 66, pp. 784-791; Mosekilde, L., Torring, O., Rejnmark, L., Emerging anabolic treatments in osteoporosis (2011) Curr Drug Saf, 6, pp. 62-74; Moyle, P.M., Toth, I., Self-adjuvanting lipopeptide vaccines (2008) Curr Med Chem, 15, pp. 506-516; Mukherjee, P., Tinder, T.L., Basu, G.D., Pathangey, L.B., Chen, L., Gendler, S.J., Therapeutic efficacy of MUC1-specific cytotoxic T lymphocytes and CD137 co-stimulation in a spontaneous breast cancer model (2004) Breast Dis, 20, pp. 53-63; Muntz, K., Deposition of storage proteins (1998) Plant Moll Biol, 38, pp. 77-99; Natilla, A., Nemchinov, L.G., Improvement of PVX/CMV CP expression tool for display of short foreign antigens (2008) Protein Expr Purif, 59, pp. 117-121; Nishida, H., Sato, T., Ogura, T., Nakaya, H., New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: mitochondrial ion channels and cardioprotection (2009) J Pharmacol Sci, 109, pp. 341-347; Nouri-Aria, K.T., Wachholz, P.A., Francis, J.N., Jacobson, M.R., Walker, S.M., Wilcock, L.K., Staple, S.Q., Durham, S.R., Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity (2004) J Immunol, 172, pp. 3252-3259; Nuzzaci, M., Piazzolla, G., Vitti, A., Lapelosa, M., Tortorella, C., Stella, I., Natilla, A., Piazzolla, P., Cucumber mosaic virus as a presentation system for a double hepatitis C virus-derived epitope (2007) Arch Virol, 152, pp. 915-928; Nuzzaci, M., Bochicchio, I., de Stradis, A., Vitti, A., Natilla, A., Piazzolla, P., Tamburro, A.M., Structural and biological properties of Cucumber mosaic virus particles carrying hepatitis C virus-derived epitopes (2009) J Virol Methods, 155, pp. 118-121; Nuzzaci, M., Vitti, A., Condelli, V., Lanorte, M.T., Tortorella, C., Boscia, D., Piazzolla, P., Piazzolla, G., In vitro stability of Cucumber mosaic virus nanoparticles carrying a Hepatitis C virus-derived epitope under simulated gastrointestinal conditions and in vivo efficacy of an edible vaccine (2010) J Virol Methods, 165, pp. 211-215; Nykiforuk, C.L., Boothe, J.G., Murray, E.W., Keon, R.G., Goren, H.J., Markley, N.A., Moloney, M.M., Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds (2006) Plant Biotechnol J, 4, pp. 77-85; Obembe, O.O., Popoola, J.O., Leelavathi, S., Reddy, S.V., Advances in plant molecular farming (2011) Biotechnol Adv, 29, pp. 210-222; Ortigosa, S.M., Fernandez-San Millan, A., Veramendi, J., Stable production of peptide antigens in transgenic tobacco chloroplasts by fusion to the p53 tetramerisation domain (2010) Transgenic Res, 19, pp. 703-709; Oude Munnink, T.H., Nagengast, W.B., Brouwers, A.H., Schroder, C.P., Hospers, G.A., Lub-de Hooge, M.N., van der Wall, E., de Vries, E.G., Molecular imaging of breast cancer (2009) Breast, 3, pp. S66-S73; Pajno, G.B., Barberi, S., The history of sublingual immunotherapy (2009) Int J Immunopathol Pharmacol, 22, pp. 1-3; Paul, M., Ma, J.K., Plant-made pharmaceuticals: leading products and production platforms (2011) Biotechnol Appl Biochem, 58, pp. 58-67; Paz de la Rosa, G., Monroy-Garcia, A., Mora-Garcia Mde, L., Pena, C.G., Hernandez-Montes, J., Weiss-Steider, B., Gomez-Lim, M.A., An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice (2009) Virol J, 6, p. 2; Phelps, J.P., Dang, N., Rasochova, L., Inactivation and purification of cowpea mosaic virus-like particles displaying peptide antigens from Bacillus anthracis (2007) J Virol Methods, 141, pp. 146-153; Pinkhasov, J., Alvarez, M.L., Rigano, M.M., Piensook, K., Larios, D., Pabst, M., Grass, J., Mason, H.S., Recombinant plant-expressed tumour-associated MUC1 peptide is immunogenic and capable of breaking tolerance in MUC1. Tg mice (2011) Plant Biotechnol J, , doi: 10. 1111/j. 1467-7652. 2011. 00614. x; Plotkin, S.A., Orenstein, W.A., Offit, P.A., (2008) Vaccines, , 5th edn., Philadelphia: Saunders/Elsevier; Pulendran, B., Ahmed, R., Immunological mechanisms of vaccination (2011) Nat Immunol, 12, pp. 509-517; Purcell, A.W., McCluskey, J., Rossjohn, J., More than one reason to rethink the use of peptides in vaccine design (2007) Nat Rev Drug Discov, 6, pp. 404-414; Qian, B., Shen, H., Liang, W., Guo, X., Zhang, C., Wang, Y., Li, G., Zhang, D., Immunogenicity of recombinant hepatitis B virus surface antigen fused with preS1 epitopes expressed in rice seeds (2008) Transgenic Res, 17, pp. 621-631; Reddish, M., Maclean, G.D., Koganty, R.R., Kan-Mitchell, J., Jones, V., Mitchell, M.S., Longenecker, B.M., Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide (1998) Int J Cancer, 76, pp. 817-823; Reglodi, D., Kiss, P., Lubics, A., Tamas, A., Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo (2011) Curr Pharm Des, 17, pp. 962-972; Robinson, W.H., Steinman, L., Human peptidome display (2011) Nat Biotech, 6, pp. 500-501; Rochlitz, C., Figlin, R., Squiban, P., Salzberg, M., Pless, M., Herrmann, R., Tartour, E., Acres, B., Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer (2003) J Gene Med, 5, pp. 690-699; Rybicki, E.P., Plant-made vaccines for humans and animals (2010) Plant Biotechnol J, 8, pp. 620-637; Schähs, M., Strasser, R., Stadlmann, J., Kunert, R., Rademacher, T., Steinkellner, H., Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern (2007) Plant Biotechnol J, 5, pp. 657-663; Scholthof, H.B., Scholthof, K.B., Jackson, A.O., Plant virus gene vectors for transient expression of foreign proteins in plants (1996) Annu Rev Phytopathol, 34, pp. 299-323; Sethi, A.A., Amar, M., Shamburek, R.D., Remaley, A.T., ApolipoproteinA-I mimetic peptides: possible new agents for the treatment of atherosclerosis (2007) Curr Opin Investig Drugs, 8, pp. 201-212; Sharma, M.K., Singh, N.K., Jani, D., Sisodia, R., Thungapathra, M., Gautam, J.K., Meena, L.S., Sharma, A.K., Expression of toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum) (2008) Plant Cell Rep, 27, pp. 307-318; Sheen, S., Biomass and chemical composition of tobacco plants under high density growth (1983) Beitr Tabakforsch Int, 12, pp. 35-42; Shinmyo, A., Kato, K., Molecular farming: production of drugs and vaccines in higher plants (2010) J Antibiot, 63, pp. 431-433; Skwarczynski, M., Toth, I., Peptide-based subunit nanovaccines (2011) Curr Drug Deliv, 8, pp. 282-289; Soria-Guerra, R.E., Rosales-Mendoza, S., Marquez-Mercado, C., Lopez-Revilla, R., Castillo-Collazo, R., Alpuche-Solis, A.G., Transgenic tomatoes express an antigenic polypeptide containing epitopes of the diphtheria, pertussis and tetanus exotoxins, encoded by a synthetic gene (2007) Plant Cell Rep, 26, pp. 961-968; Soria-Guerra, R.E., Rosales-Mendoza, S., Moreno-Fierros, L., Lopez-Revilla, R., Alpuche-Solis, A.G., Oral immunogenicity of tomato-derived sDPT polypeptide containing Corynebacterium diphtheriae, Bordetella pertussis and Clostridium tetani exotoxin epitopes (2011) Plant Cell Rep, 30, pp. 417-424; Sriraman, R., Bardor, M., Sack, M., Vaquero, C., Faye, L., Fischer, R., Finnern, R., Lerouge, P., Recombinant anti-hCG antibodies retained in the endoplasmic reticulum of transformed plants lack core-xylose and core-α(1, 3)fucose residues (2004) Plant Biotechnol J, 2, pp. 279-287; Stevenson, C.L., Advances in peptide pharmaceuticals (2009) Curr Pharm Biotechnol, 10, pp. 122-137; Strasser, R., Altmann, F., Mach, L., Glossl, J., Steinkellner, H., Generation of Arabidopsis thaliana plants with complex N-glycans lacking β1, 2-linked xylose and core α1, 3-linked fucose (2004) FEBS Lett, 561, pp. 132-136; Strasser, R., Stadlmann, J., Schähs, M., Stiegler, G., Quendler, H., Mach, L., Glössl, J., Steinkellner, H., Generation of glycoengineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure (2008) Plant Biotechnol J, 6, pp. 392-402; Strasser, R., Castilho, A., Stadlmann, J., Kunert, R., Quendler, H., Gattinger, P., Jez, J., Steinkellner, H., Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous β1, 4-galactosylated N-glycan profile (2009) J Biol Chem, 284, pp. 20479-20485; Suzuki, K., Kaminuma, O., Yang, L., Takai, T., Mori, A., Umezu-Goto, M., Ohtomo, T., Takaiwa, F., Prevention of allergic asthma by vaccination with transgenic rice seed expressing mite allergen: induction of allergen-specific oral tolerance without bystander suppression (2011) Plant Biotechnol J, , doi: 10. 1111/j. 1467-7652. 2011. 00613. x; Takagi, H., Hiroi, T., Yang, L., Takamura, K., Ishimitsu, R., Kawauchi, H., Takaiwa, F., Efficient induction of oral tolerance by fusing cholera toxin B subunit with allergen-specific T-cell epitopes accumulated in rice seed (2008) Vaccine, 26, pp. 6027-6030; Takagi, H., Hiroi, T., Hirose, S., Yang, L., Takaiwa, F., Rice seed ER-derived protein body as an efficient delivery vehicle for oral tolerogenic peptides (2010) Peptides, 31, pp. 1421-1425; Takaiwa, F., Takagi, H., Hirose, S., Wakasa, Y., Endosperm tissue is good production platform for artificial recombinant proteins in transgenic rice (2007) Plant Biotechnol J, 5, pp. 84-92; Takaiwa, F., Hirose, S., Takagi, H., Yang, L., Wakasa, Y., Deposition of a recombinant peptide in ER-derived protein bodies by retention with cysteine-rich prolamins in transgenic rice seed (2009) Planta, 229, pp. 1147-1158; Tribbick, G., Multipin peptide libraries for antibody and receptor epitope screening and characterization (2002) J Immunol Methods, 267, pp. 27-35; Triguero, A., Cabrera, G., Cremata, J.A., Yuen, C.T., Wheeler, J., Ramírez, N.I., Plant-derived mouse IgG monoclonal antibody fused to KDEL endoplasmic reticulum-retention signal is N-glycosylated homogeneously throughout the plant with mostly high-mannose-type N glycans (2005) Plant Biotechnol J, 3, pp. 449-457; van den Eynde, B.J., van der Bruggen, P., T cell defined tumor antigens (1997) Curr Opin Immunol, 9, pp. 684-693; Vitti, A., Piazzolla, G., Condelli, V., Nuzzaci, M., Lanorte, M.T., Boscia, D., de Stradis, A., Tortorella, C., Cucumber mosaic virus as the expression system for a potential vaccine against Alzheimer’s disease (2010) J Virol Methods, 169, pp. 332-340; Vlieghe, P., Lisowski, V., Martinez, J., Khrestchatisky, M., Synthetic therapeutic peptides: science and market (2010) Drug Discov Today, 15, pp. 40-56; Wakasa, Y., Tamakoshi, C., Ohno, T., Hirose, S., Goto, T., Nagaoka, S., Takaiwa, F., The hypocholesterolemic activity of transgenic rice seed accumulating lactostatin, a bioactive peptide derived from bovine milk beta-lactoglobulin (2011) J Agric Food Chem, 59, pp. 3845-3850; Wakasa, Y., Zhao, H., Hirose, S., Yamauchi, D., Yamada, Y., Yang, L., Ohinata, K., Takaiwa, F., Antihypertensive activity of transgenic rice seed containing an 18-repeat novokinin peptide localized in the nucleolus of endosperm cells (2011) Plant Biotechnol J, 9, pp. 729-735; Webb, A.I., Dunstone, M.A., Williamson, N.A., Price, J.D., de Kauwe, A., Chen, W., Oakley, A., Purcell, A.W., T cell determinants incorporating beta-amino acid residues are protease resistant and remain immunogenic in vivo (2005) J Immunol, 175, pp. 3810-3818; Wu, D., Lee, D., Sung, Y.K., Prospect of vasoactive intesstinal peptide therapy for COPD/PAH and asthma: a review (2011) Respir Res, 11, pp. 12-45; Yang, C.D., Liao, J.T., Lai, C.Y., Jong, M.H., Liang, C.M., Lin, Y.L., Lin, N.S., Liang, S.M., Induction of protective immunity in swine by recombinant bamboo mosaic virus expressing foot-and-mouth disease virus epitopes (2007) BMC Biotechnol, 7, p. 62; Yusibov, V., Mett, V., Mett, V., Davidson, C., Muslychuk, K., Gilliam, S., Farese, A., Mann, D., Peptide-based candidate vaccine against respiratory syncytial virus (2005) Vaccine, 23, pp. 2261-2265; Zhang, Y., Li, J., Pu, H., Jin, J., Zhang, X., Chen, M., Wang, B., Li, D., Development of Tobacco necrosis virus A as a vector for efficient and stable expression of FMDV VP1 peptides (2010) Plant Biotechnol J, 8, pp. 506-523; Zhong, W., Skwarczynski, M., Toth, I., Lipid core peptide system for gene, drug and vaccine delivery (2009) Aust J Chem, 62, pp. 956-967